Home > News > Nanogen Issued Patent for Electronic Devices
May 5th, 2004
Nanogen Issued Patent for Electronic Devices
Nanogen, Inc., developer of molecular and point-of-care diagnostic products, announced today that it was issued U.S. Patent No. 6,726,880, "Electronic Devices for Performing Active Biological Operations and Method of Using Same," by the U.S. Patent and Trademark Office. The '880 patent relates to new devices that enable increased sensitivity of active, programmable electronic matrix (APEX) devices and perform actions such as concentration and assembly of biological materials on a substrate.
Silicon Valley-Based Foresight Valuation Launches STR-IP™, a New Initiative for Startups to Discover the Value of Their Intellectual Property December 18th, 2014
Chemists Fabricate Novel Rewritable Paper: An attractive alternate to regular paper, UC Riverside-developed technology helps address increasing problems in environment and resource sustainability December 2nd, 2014
Dicerna Announces License Agreement with Tekmira to Advance Dicerna’s PH1 Development Program November 17th, 2014
First genetic-based tool to detect circulating cancer cells in blood: NanoFlares light up individual cells if breast cancer biomarker is present November 17th, 2014